Sage therapeutics articles
-
Sage Therapeutics (NASDAQ:SAGE) Price Target Cut to $25.00 by Analysts at HC Wainwright
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price objective reduced by stock analysts at HC Wainwright from $28.00 to $25.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside […]
-
Beam Therapeutics (NASDAQ:BEAM) Shares Down 6.6%
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) dropped 6.6% on Thursday . The stock traded as low as $20.84 and last traded at $21.23. Approximately 468,916 shares were traded during trading, a decline of 67% from the average daily volume of 1,435,909 shares. The stock had previously closed at $22.74. Wall Street Analysts Forecast […]
-
Relay Therapeutics (NASDAQ:RLAY) Shares Down 7.6%
Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report)’s stock price dropped 7.6% during mid-day trading on Thursday . The stock traded as low as $5.83 and last traded at $5.87. Approximately 127,207 shares were traded during mid-day trading, a decline of 89% from the average daily volume of 1,136,857 shares. The stock had previously closed […]